Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies

Prenatal Diagnosis

Volumn 25, Issue 3, 2005, Pages 234-238

  Rice, Jennifer D ^a   McIntosh, Sarah F ^b   Halstead, Anne C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VICTORIA GENERAL HOSPITAL   (Canada)

Author keywords

Down syndrome; Human chorionic gonadotrophin; In vitro fertilization; Maternal serum screening; Triple screen

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ARTICLE; BLOOD SAMPLING; CANADA; CONTROLLED STUDY; DATA ANALYSIS; DOWN SYNDROME; ESTRIOL BLOOD LEVEL; FERTILIZATION IN VITRO; FETUS; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; MATERNAL AGE; MATERNAL SERUM; PATIENT COUNSELING; PRENATAL SCREENING; PRIORITY JOURNAL; SCREENING TEST; SECOND TRIMESTER PREGNANCY;

ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; DOWN SYNDROME; ESTRIOL; FEMALE; FERTILIZATION IN VITRO; FETAL DISEASES; HUMANS; MASS SCREENING; PREGNANCY; PREGNANCY TRIMESTER, SECOND;

EID: 16444367571     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.1116     Document Type: Article

References (14)

1. Bar-Hava I, Yitzhak M, Krissi H, et al. 2001. Triple-test screening in in-vitro fertilization pregnancies. J Assist Reprod Genet 18(4): 226-229.
2. Barkai G, Goldman B, Ries L, Chaki R, Dor J, Cuckle H. 1996. Down's syndrome screening marker levels following assisted reproduction. Prenat Diagn 16: 1111-1114.
3. Frishman GN, Canick JA, Hogan JW, Hackett RJ, Kellner LH, Saller DN. 1997. Serum triple marker screening in in-vitro fertilization and naturally conceived pregnancies. Obstet Gynecol 90: 98-101.
4. Heinonen S, Ryyanen M, Kirkenen P, Hippelainen M, Saarikoski S. 1996. Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down's syndrome screening. Fertil Steril 66(3): 398-403.
5. Knight GJ, Palomaki GE. 2003. Epidemiologic monitoring of prenatal screening for neural tube defects and Down syndrome. Clin Lab Med 23(2): 531-551.
6. Lam YH, Yeung WSB, Tang MHY, Ng EHY, So WWK, Ho PC. 1999. Maternal serum alpha-fetoprotein and human chorionic gonadotrophin in pregnancies conceived after intracytoplasmic sperm injection and conventional in vitro fertilization. Hum Reprod 14(8): 2120-2123.
7. Maymon R, Shulman A. 2001. Comparison of triple serum screening and pregnancy outcome in oocyte donation versus IVF pregnancies. Hum Reprod 16(4): 691-695.
8. Maymon R, Shulman A. 2002. Serial first and second trimester Down's syndrome screening tests among IVF versus naturally conceived singletons. Hum Reprod 17(4): 1081-1085.
9. Maymon R, Dreazen E, Rozinsky S, Bukovsky I, Weinraub Z, Herman A. 1999. Comparison of nuchal translucency measurement and mid-gestation serum screening in assisted reproduction versus naturally conceived singleton pregnancies. Prenat Diagn 19: 1007-1011.
10. Muller F, Aegerter P, Boue A. 1993. Prospective maternal serum human chorionic gonadotropin screening for the risk of fetal chromosome anomalies and of subsequent fetal and neonatal deaths. Prenat Diagn 13: 29-43.
11. Muller F, Dreux S, Lemeur A, et al. 2003. Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome. Prenat Diagn 23: 1073-1076.
12. Raty R, Virtanen A, Koshinen P, et al. 2002. Serum free β-HCG and alpha-fetoprotein levels in IVF, ICSI and frozen embryo transfer pregnancies in maternal mid-trimester serum screening for Down's syndrome. Hum Reprod 17(2): 481-484.
13. Ribbert LSM, Kornman LH, De Wolf BTHM, et al. 1996. Maternal serum screening for fetal Down syndrome in IVF pregnancy. Prenat Diagn 16: 35-38.
14. Wald NJ, White N, Morris JK, Huttly WJ, Canick JA. 1999. Serum markers for Down's syndrome in women who have had in vitro fertilization: implications for antenatal screening. Br J Obstet Gynaecol 106: 1304-1306.